Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2005 | Volume: 1 | Issue: 1 | Page No.: 74-78
DOI: 10.3923/ijp.2005.74.78
Effects of Chronic Lead Exposure on Aminoglycosides-induced Changes in Guina Pig Auditory Brainstem Responses
Mohammad Sharifzadeh, Mahsa Raoufi , Amir Abbas Zahedinejad , Nourollah Aghaebrahimi , Kurdistan Sharifzadeh and Mohammad Abdollahi

Abstract:
The effects of chronic lead acetate treatment on alterations of Auditory Brainstem Response (ABR) induced by gentamicin and amikacin were tested in guinea pigs. This study was designed to investigate the hypothesis that aminoglycoside antibiotics and lead via their effects on phosphoinositide pathway and calcium channels may influence ototoxicity mechanisms as tested on the auditory brainstem response. Intramuscular injection of different doses of gentamicin (5, 10 mg/kg/day) and amikacin (150, 300 mg/kg/day) for three weeks induced hearing loss. Administration of lead acetate (0.05%, 35 days) in drinking water changed ABR (absolute wave latency). The gentamicin-induced alteration of ABR were attenuated by chronic lead acetate pretreatment in guinea pig. Obtained data suggest the interactions between chronic lead acetate and aminoglycoside antibiotics in alterations of auditory functions which could be accounted for, at least partially, by perturbations of the phosphoinositide and calcium cascades within the inner ear.
PDF References Citation Report Citation
How to cite this article:

Mohammad Sharifzadeh, Mahsa Raoufi , Amir Abbas Zahedinejad , Nourollah Aghaebrahimi , Kurdistan Sharifzadeh and Mohammad Abdollahi , 2005. Effects of Chronic Lead Exposure on Aminoglycosides-induced Changes in Guina Pig Auditory Brainstem Responses. International Journal of Pharmacology, 1: 74-78.

DOI: 10.3923/ijp.2005.74.78

URL: https://scialert.net/abstract/?doi=ijp.2005.74.78

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom